If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXp Power Regulatory News (XPP)

Share Price Information for Xp Power (XPP)

Share Price is delayed by 15 minutes
Get Live Data
1,930.00    -6.00 (-0.31%)
Bid:
1,940.00
Ask:
1,948.00
Spread: 8.00 (0.412%)
Market Cap: £541.02m
XPP Live PriceLast checked at - London Stock Exchange

Intraday Xp Power Share Chart

Dividend Date Correction

12 Oct 2020 09:20

XP POWER LTD - Dividend Date Correction

XP POWER LTD - Dividend Date Correction

PR Newswire

London, October 12

12 October 2020

XP Power Limited(“XP Power” or “the Group”)

Dividend date correction

As announced with the Group’s Q3 trading update this morning, XP Power has declared a dividend for the third quarter of 20 pence per share. The record date of 15 December 2020 included in that announcement was incorrect. The dividend will in fact be paid on 15 January 2021 to shareholders on the register on 11 December 2020. All other details included in the amended announcement below remain unchanged.

Q3 Trading Update

XP Power, one of the world's leading developers and manufacturers of critical power control components to the electronics industry, is today issuing a trading update for the third quarter and nine months ended 30 September 2020 and a further update on the impact of COVID-19.

COVID-19

We are continuing to monitor the global situation in respect of COVID-19. The health, safety and well-being of our colleagues remains our first priority and we are providing our teams with our full support, following all public health advice, and complying with all government directives.

We are pleased to report that during the third quarter all of our manufacturing and logistics facilities around the world have been operating normally, with epidemic and prevention controls in place in line with all public health advice.

Trading

Revenue in the third quarter progressed positively as the exceptionally strong order intake we saw in the first half translated into product shipments. Order intake continues to be encouraging driven by demand in the Semiconductor Equipment Manufacturing sector. Healthcare orders have now returned to normal levels, following the COVID-19 related demand we saw in the first six months of 2020. Overall, orders were up 29% for the nine months ended 30 September 2020 compared with the prior year, including a £15-20 million net increase linked to COVID-19.

Production volumes from our Asian manufacturing facilities increased significantly in the third quarter as we ramped up production to meet demand. This delivered significantly increased revenues in the third quarter as we fulfilled the sizeable backlog of Healthcare and Semiconductor Equipment Manufacturing orders received during the first half. The book to bill ratio, which tracks the relationship between orders received and completed sales, was 0.82 for the third quarter (2019: 1.04) reflecting the strong production volumes and revenue growth in the period. The year-to-date book to bill is 1.16 (2019: 1.02).

£ Millions20202019ChangeChange in constant currency
Orders
Third quarter56.355.91%2%
Year to date202.1156.529%33%
Revenues
Third quarter69.053.828%32%
Year to date174.1152.714%13%
Book to Bill
Third quarter0.821.04-0.22
Year to date1.161.020.14

Financial position and dividend

Net debt at 30 September 2020 was £28.2 million, compared to £34.4 million at 30 June 2020, and the Group has immediately available committed liquidity of c.£64 million through bank facilities and cash balances (30 June 2020: c.£61 million). The Group will continue its disciplined approach to capital allocation, prioritising a strong balance sheet.

After considering the above the Board is proposing a dividend for the third quarter of 20 pence per share (2019: 20 pence per share) which will be paid on 15 January 2021 to shareholders on the register on 11 December 2020.

CEO Succession

The intention of Duncan Penny to retire as CEO at the end of 2020 and the appointment of Gavin Griggs, current CFO, as new CEO with effect from 1 January 2021, has been announced separately today.

Outlook

We enter the final quarter of 2020 in a healthy position, with an order backlog of £125.7 million (30 June 2020: £138.2 million), due to the COVID-19 related Healthcare demand experienced in the first half and the ongoing cyclical recovery of the Semiconductor Equipment Manufacturing sector. While demand across all sectors remains generally encouraging, Healthcare orders have now normalised, and we do not expect a repeat of the exceptional demand experienced earlier in the year. Our manufacturing facilities have successfully increased production to fulfil this demand, underpinning a robust third quarter revenue performance and our outlook for the final quarter.

The Board anticipates the Group’s performance for full year 2020 will be towards the top end of current analyst expectations, although we remain conscious of potential risks arising from a second wave of COVID-19 and the resultant global macroeconomic impact, and ongoing trade tensions. The Board remains confident in the long-term market opportunity for the Group, supported by the structural growth drivers in the marketplace, and in our ability to capture this opportunity.

Enquiries:

XP Power 

Duncan Penny, Chief Executive Officer +44 (0)118 976 5515

Gavin Griggs, Chief Financial Officer +44 (0)118 976 5515

Citigate Dewe Rogerson

Kevin Smith/Jos Bieneman +44 (0)207 638 9571

Note to editors

XP Power designs and manufactures power controllers, the essential hardware component in every piece of electrical equipment that converts power from the electricity grid into the right form for equipment to function.

XP Power typically designs power control solutions into the end products of major blue-chip OEMs, with a focus on the Industrial Electronics (c.33% of revenue), Healthcare (c.29% of revenue), Semiconductor Equipment Manufacturing (c.28% of revenue) and Technology (c.10% of revenue) sectors. Once designed into a programme, XP Power has a revenue annuity over the life cycle of the customer’s product which is typically 5 to 7 years depending on the industry sector.

XP Power has invested in research and development and its own manufacturing facilities in China and Vietnam, to develop a range of tailored products based on its own intellectual property that provide its customers with significantly improved functionality and efficiency.

Headquartered in Singapore and listed on the Main Market of the London Stock Exchange since 2000, XP Power is a constituent of the FTSE 250 Index. XP Power serves a global blue-chip customer base from 29 locations in Europe, North America, and Asia. 

For further information, please visit xppower.com

Date   Source Headline
23rd Mar 200610:25 amRNSTransaction in Own Shares
16th Mar 20065:35 pmRNSDirector/PDMR Shareholding
16th Mar 20062:54 pmRNSTransaction in Own Shares
10th Mar 20064:00 pmRNSDirectorate Change
9th Mar 20062:41 pmRNSTransaction in Own Shares
7th Mar 200612:46 pmRNSTransaction in Own Shares
1st Mar 20066:28 pmRNSHolding(s) in Company
23rd Feb 200611:17 amRNSTransaction in Own Shares
22nd Feb 20067:00 amRNSTransaction in Own Shares
21st Feb 20062:47 pmRNSTransaction in Own Shares
15th Feb 200612:55 pmRNSTransaction in Own Shares
14th Feb 20063:53 pmRNSHolding(s) in Company
10th Feb 20065:12 pmRNSTransaction in Own Shares
7th Feb 200612:26 pmRNSAmendment to Final Results
7th Feb 20067:02 amRNSFinal Results
16th Jan 200610:00 amRNSNotice of Results
21st Dec 20052:31 pmRNSHolding(s) in Company
9th Dec 20054:49 pmRNSDirector/PDMR Shareholding
6th Dec 200512:05 pmRNSTransaction in Own Shares
21st Nov 20053:03 pmRNSHolding(s) in Company
17th Nov 20056:12 pmRNSTransaction in Own Shares
11th Nov 20056:13 pmRNSHolding(s) in Company
9th Nov 20055:19 pmRNSTransaction in Own Shares
8th Nov 20057:00 amRNSTrading Statement
28th Oct 20059:30 amRNSAcquisition
20th Oct 200511:09 amRNSTransaction in Own Shares
10th Oct 200511:04 amRNSTransaction in Own Shares
10th Oct 20059:02 amRNSTransaction in Own Shares
4th Oct 20055:01 pmRNSTransaction in Own Shares
11th Aug 20059:16 amRNSTransaction in Own Shares
2nd Aug 20056:21 pmRNSInterim Results - Replacement
2nd Aug 20057:01 amRNSInterim Results
28th Jul 20056:30 pmRNSHolding(s) in Company
27th Jul 200510:47 amRNSHolding(s) in Company
7th Jul 20051:43 pmRNSNotice of Results
17th Jun 200510:48 amRNSHolding(s) in Company
10th Jun 20057:00 amRNSDirectorate Change
21st Apr 20057:00 amRNSTrading Statement
20th Apr 20056:00 pmRNSAGM Statement
24th Mar 200512:42 pmRNSTransaction in Own Shares
18th Mar 200510:35 amRNSTransaction in Own Shares
18th Feb 20059:20 amRNSTransaction in Own Shares
17th Feb 200510:01 amRNSHolding(s) in Company
15th Feb 200511:15 amRNSDirector Shareholding
14th Feb 20054:40 pmRNSHolding(s) in Company
11th Feb 20055:15 pmRNSDirector Shareholding
10th Feb 20053:06 pmRNSHolding(s) in Company
9th Feb 20053:27 pmRNSDirector Shareholding
8th Feb 20055:02 pmRNSDirector Shareholding
1st Feb 20057:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.